VIRAL VECTOR DEVELOPMENT & ANALYTICS

Expertise at the intersection of virology, analytics & CMC.

Brenna Kelley-Clarke, Ph.D. is a virologist and viral vector development leader with more than 15 years experience advancing gene and cell therapy programs.

Illustration of viruses
Scientist performing gene therapy analytics

Areas of Expertise

  • Viral vector analytics

  • Vector CMC & process development

  • Development strategy

Selected Experience:

  • Senior Director and Head of Vector Attribute Sciences at Bristol Myers Squibb

  • Leadership of teams spanning viral vector analytics, formulations, and process development

  • AAV and lentiviral vector programs across early and late-stage development

  • Analytical and CMC support for regulatory submissions (IND and BLA)

  • Experience supporting both in vivo and ex vivo gene and cell therapy approaches

  • Expert witness in a federal intellectual property dispute involving viral vector analytics

Meet Brenna